Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11620323 | 0.87 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL9154522 | 0.74 | MEN1 (0.43) | MEN1KMT2AALDH1A1HSD17B10 | |
| SCHEMBL2760958 | 0.72 | MEN1 (0.41) | MEN1KMT2AALDH1A1HSD17B10 | |
| Methoxyflurane SCHEMBL121229 | 0.72 | — | — | |
| SCHEMBL1991659 | 0.70 | — | — | |
| Methoxyflurane SCHEMBL27525605 | 0.69 | — | — | |
| SCHEMBL11419898 | 0.69 | MEN1 (0.39) | MEN1KMT2A | |
| SCHEMBL20772959 | 0.65 | — | — | |
| SCHEMBL9066678 | 0.65 | ALDH1A1 (0.54) | MEN1KMT2AALDH1A1HSD17B10 | |
| SCHEMBL65852 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12551570-B2 | Compounds comprising cleavable linker and uses thereof | INTOCELL, INC. (KR) | 2026-02-17 | — | — | US | disclosed |
| US-12479927-B2 | Compounds comprising cleavable linker and uses thereof | INTOCELL, INC. (KR) | 2025-11-25 | — | — | US | disclosed |
| US-20250213712-A1 | ANTIBODY DRUG CONJUGATES COMPRISING CAMPTOTHECIN DERIVATIVES AND USES THEREOF | INTOCELL, INC. (KR) | 2025-07-03 | — | — | US | disclosed |
| US-12274898-B2 | Substituted benzodiazepines as antibody-drug conjugates | INTOCELL, INC. (KR) | 2025-04-15 | — | — | US | disclosed |
| EP-4452328-A1 | ANTIBODY DRUG CONJUGATES COMPRISING TOXINS WITH POLAR GROUPS AND USES THEREOF | Intocell, Inc. (KR) | 2024-10-30 | — | — | EP | disclosed |
| US-20230406877-A1 | COMPOUNDS COMPRISING CLEAVABLE LINKER AND USES THEREOF | INTOCELL, INC. (KR) | 2023-12-21 | — | — | US | disclosed |
| US-11807628-B2 | Benzodiazepine derivatives and uses thereof | INTOCELL, INC. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-11753431-B2 | Compounds comprising cleavable linker and uses thereof | INTOCELL, INC. (KR) | 2023-09-12 | — | — | US | disclosed |
| WO-2023118961-A1 | ANTIBODY DRUG CONJUGATES COMPRISING TOXINS WITH POLAR GROUPS AND USES THEREOF | INTOCELL, INC. (KR) | 2023-06-29 | — | — | WO | disclosed |
| US-20230190939-A1 | ANTIBODY DRUG CONJUGATES COMPRISING TOXINS WITH POLAR GROUPS AND USES THEREOF | INTOCELL, INC. (KR) | 2023-06-22 | — | — | US | disclosed |
| WO-2008061032-A1 | OPTICAL DATA RECORDING AND IMAGING ON MEDIA USING APOCHROMATIC LENSES | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2008-05-22 | — | — | WO | disclosed |
| WO-2008061030-A1 | OPTICAL DATA RECORDING AND IMAGING ON MEDIA USING APOCHROMATIC LENSES AND A LIGHT SEPARATING MEANS | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2008-05-22 | — | — | WO | disclosed |
| US-20080050672-A1 | LIGHT ACTIVATED CONTRAST SYSTEMS USING MASKED DEVELOPERS FOR OPTICAL DATA RECORDING | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2008-02-28 | — | — | US | disclosed |
| WO-2008024984-A1 | LIGHT ACTIVATED CONTRAST SYSTEMS USING MASKED DEVELOPERS FOR OPTICAL DATA RECORDING | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2008-02-28 | — | — | WO | disclosed |
| US-20070265296-A1 | Nuclear receptor binding agents | GTX, INC. | 2007-11-15 | — | — | US | disclosed |
| WO-2007062230-A2 | NUCLEAR RECEPTOR BINDING AGENTS | GTX, INC. (US) | 2007-05-31 | — | — | WO | disclosed |
| US-20050254551-A1 | Temperature monitoring system | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2005-11-17 | — | — | US | disclosed |
| US-6958181-B1 | Protected activators for use in leuco dye compositions | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2005-10-25 | — | — | US | disclosed |
| US-20050227034-A1 | PROTECTED ACTIVATORS FOR USE IN LEUCO DYE COMPOSITIONS | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2005-10-13 | — | — | US | disclosed |
| WO-2005025885-A1 | PROTECTED ACTIVATORS FOR USE IN LEUCO DYE COMPOSITIONS | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2005-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230190939-A1 | ANTIBODY DRUG CONJUGATES COMPRISING TOXINS WITH POLAR GROUPS AND USES THEREOF | CD47, ENPP2, CD2 | MEN1 1660/4885KMT2A 3159/4885ALDH1A1 4468/4885 |
| US-11807628-B2 | Benzodiazepine derivatives and uses thereof | GABRB3, GABRB2, GABRB1 | MEN1 3799/4885KMT2A 1869/4885ALDH1A1 900/4885 |
| US-20250213712-A1 | ANTIBODY DRUG CONJUGATES COMPRISING CAMPTOTHECIN DERIVATIVES AND USES THEREOF | CD47, TOP2A, SSB | MEN1 1190/4885KMT2A 2535/4885ALDH1A1 2732/4885 |
| US-12551570-B2 | Compounds comprising cleavable linker and uses thereof | FCGR2A, FCGR3B, FCGR1A | MEN1 3990/4885KMT2A 3562/4885ALDH1A1 4586/4885 |
| US-20070265296-A1 | Nuclear receptor binding agents | GPER1, ESRRG, ESR2 | MEN1 1408/4885KMT2A 1506/4885ALDH1A1 3644/4885 |
| US-20230406877-A1 | COMPOUNDS COMPRISING CLEAVABLE LINKER AND USES THEREOF | VIP, ANTXR2, TNFRSF9 | MEN1 3064/4885KMT2A 3544/4885ALDH1A1 4822/4885 |
| US-12479927-B2 | Compounds comprising cleavable linker and uses thereof | VIP, ANTXR2, TNFRSF9 | MEN1 3064/4885KMT2A 3544/4885ALDH1A1 4822/4885 |
| US-11753431-B2 | Compounds comprising cleavable linker and uses thereof | VIP, ANTXR2, TNFRSF9 | MEN1 3064/4885KMT2A 3544/4885ALDH1A1 4822/4885 |
| US-12274898-B2 | Substituted benzodiazepines as antibody-drug conjugates | GABRA3, GABRA6, GABRA4 | MEN1 3404/4885KMT2A 828/4885ALDH1A1 207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.